Chicago Partners Investment Group LLC Grows Stock Holdings in CME Group Inc. $CME

Chicago Partners Investment Group LLC raised its holdings in shares of CME Group Inc. (NASDAQ:CME) by 0.2% in the 2nd quarter, Holdings Channel.com reports. The firm owned 26,403 shares of the financial services provider’s stock after buying an additional 58 shares during the quarter. Chicago Partners Investment Group LLC’s holdings in CME Group were worth $7,300,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. Wayfinding Financial LLC bought a new position in shares of CME Group in the 1st quarter valued at about $25,000. Webster Bank N. A. raised its position in CME Group by 206.9% during the second quarter. Webster Bank N. A. now owns 89 shares of the financial services provider’s stock valued at $25,000 after purchasing an additional 60 shares during the period. Cornerstone Planning Group LLC lifted its stake in shares of CME Group by 122.2% in the 1st quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 55 shares during the last quarter. Highline Wealth Partners LLC lifted its stake in shares of CME Group by 84.3% in the 2nd quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 43 shares during the last quarter. Finally, Golden State Wealth Management LLC boosted its holdings in shares of CME Group by 612.5% in the 1st quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider’s stock worth $30,000 after purchasing an additional 98 shares during the period. 87.75% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at CME Group

In other CME Group news, insider Sunil Cutinho sold 11,896 shares of the firm’s stock in a transaction on Tuesday, August 26th. The stock was sold at an average price of $271.47, for a total transaction of $3,229,407.12. Following the transaction, the insider directly owned 17,440 shares in the company, valued at $4,734,436.80. This trade represents a 40.55% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director William R. Shepard bought 262 shares of the firm’s stock in a transaction on Thursday, September 25th. The shares were purchased at an average cost of $265.19 per share, with a total value of $69,479.78. Following the completion of the transaction, the director owned 258,459 shares in the company, valued at $68,540,742.21. This represents a 0.10% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders sold 13,043 shares of company stock worth $3,527,956 in the last ninety days. 0.30% of the stock is owned by company insiders.

Analyst Ratings Changes

CME has been the subject of a number of analyst reports. Piper Sandler raised their price target on CME Group from $283.00 to $296.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 15th. Wall Street Zen downgraded shares of CME Group from a “hold” rating to a “sell” rating in a research note on Sunday, July 13th. Morgan Stanley raised their target price on shares of CME Group from $303.00 to $312.00 and gave the stock an “overweight” rating in a report on Wednesday, October 1st. Raymond James Financial cut their price target on shares of CME Group from $309.00 to $307.00 and set an “outperform” rating on the stock in a report on Monday, October 13th. Finally, Deutsche Bank Aktiengesellschaft reduced their price objective on shares of CME Group from $276.00 to $266.00 and set a “hold” rating on the stock in a research report on Thursday, October 9th. Seven research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $283.71.

CME Group Stock Up 2.1%

Shares of CME opened at $267.93 on Friday. The firm has a fifty day moving average price of $267.30 and a 200-day moving average price of $271.38. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. The firm has a market capitalization of $96.56 billion, a P/E ratio of 25.94, a P/E/G ratio of 6.16 and a beta of 0.41. CME Group Inc. has a 12-month low of $213.94 and a 12-month high of $290.79.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share for the quarter, beating analysts’ consensus estimates of $2.91 by $0.05. The company had revenue of $1.69 billion during the quarter, compared to analyst estimates of $1.68 billion. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The firm’s revenue for the quarter was up 10.4% on a year-over-year basis. During the same quarter last year, the business posted $2.56 EPS. Equities research analysts expect that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, September 25th. Investors of record on Tuesday, September 9th were issued a $1.25 dividend. The ex-dividend date was Tuesday, September 9th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.9%. CME Group’s payout ratio is presently 48.40%.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.